Cleveland Heights, OH, United States of America

Sepideh Azarianpour Esfahani

Average Co-Inventor Count = 3.0

ph-index = 1


Years Active: 2024

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: **Inventor Spotlight: Sepideh Azarianpour Esfahani**

Introduction

Sepideh Azarianpour Esfahani is a notable inventor based in Cleveland Heights, OH, who has made significant contributions in the field of medical research, particularly focusing on cancer prognosis. Her innovative work is characterized by the application of computational methods in the analysis of tumor-infiltrating lymphocyte (TIL) architecture.

Latest Patents

Sepideh Azarianpour Esfahani holds one patent titled "Computational features of tumor-infiltrating lymphocyte (TIL) architecture." This patent describes a method for generating a risk group classification specifically for African American (AA) patients. It involves extracting a plurality of architectural features from digitized H&E slide images of the patients. The invention generates a risk score that is prognostic of overall survival, allowing for the classification of the AA patient into high-risk or low-risk groups based on the generated scores.

Career Highlights

Currently, Azarianpour Esfahani is affiliated with the University of Pittsburgh, where she engages in research efforts aimed at improving cancer treatment outcomes through innovative computational techniques. Her patent underscores her commitment to integrating technology with health sciences to enhance patient prognostication.

Collaborations

Throughout her career, Sepideh has collaborated with esteemed colleagues, including Anant Madabhushi and Haider Mahdi. These collaborations reflect her engagement with leading experts in the field, fostering an environment of innovation and shared knowledge.

Conclusion

Sepideh Azarianpour Esfahani exemplifies the intersection of technology and medical research through her inventive solutions. Her patent contributions are paving the way for better understanding and treatment of cancer, demonstrating her dedication to improving healthcare outcomes for diverse populations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…